Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colonic Delivery of Butyrate in Type 1 Diabetes
NCT03999853Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Jul 2022
- Primary completion
- Apr 2025
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of BKR-017 in type 1 diabetes mellitus (T1D), sponsored by Mayo Clinic. Started Jul 2022; status: completed.
02
Drugs
BKR-017
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03999853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03999853.